Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus cisplatin with concurrent radiation for locally advanced thymic carcinoma
jRCTs071180046Phase 2Completed
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur and cisplatin in thymic carcinoma (TC). Primary endpoint: response rate. Started Jan 2017; status: completed.
02
Drugs
tegafurcisplatin
03
Conditions
thymic carcinoma (TC)
Beyond the preview
Go deeper on jRCTs071180046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180046.